FritzRSHaydenFGCalfeeDP. Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis1999;180:586–93.
2.
SheeranPJafriHCarubelliC. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J1999;18:115–22.
3.
BontLHeijnenCJKavelaarsA. Local interferongamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis2001;184:355–8.
4.
HornslethALolandLLarsenLB. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol2001;21:163–70.
5.
HeikkinenTThintMChonmaitreeT. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med1999;340:260–4.
6.
El AhmerORRazaMWOgilvieMMWeirDMBlackwellCC. Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol Med Microbiol1999;23:331–41.
7.
TongHHFisherLMKosunickGMDeMariaTF. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann Otol Rhinol Laryngol2000;109:1021–7.
8.
TongHHChenYJamesMVan DeusenJWellingDBDeMariaTF. Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants. Infect Immun2001;69:3678–84.
9.
McCullersJABartmessKC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis2003;187:1000–9.
10.
WintherBHaydenFGArrudaEDutkowskiRWardPHendleyJO. Viral respiratory infection in schoolchildren: Effects on middle ear pressure. Pediatrics2002;109:826–32.
11.
BuchmanCADoyleWJPilcherOGentileDASkonerDP. Nasal and otologic effects of experimental respiratory syncytial virus infection in adults. Am J Otolaryngol2002;23:70–5.
12.
StenforsLEByeHMRaisanenS. Causes for massive bacterial colonization on mucosal membranes during infectious mononucleosis: Implications for acute otitis media. Int J Pediatr Otorhinolaryngol2002;65:233–40.
13.
VesaSKleemolaMBlomqvistSTakalaAKilpiTHoviT. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J2001;20:574–81.
14.
KotikoskiMJPalmuAANokso-KoivistoJKleemolaM. Evaluation of the role of respiratory viruses in acute myringitis in children less than two years of age. Pediatr Infect Dis J2002;21:636–41.
15.
McCormickDPLim-MeliaESaeedKBaldwinCDChonmaitreeT. Otitis media: Can clinical findings predict bacterial or viral etiology?. Pediatr Infect Dis J2000;19:256–8.
16.
HeikkinenTChonmaitreeT. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev2003;16:230–41.
17.
ChonmaitreeTHenricksonKJ. Detection of respiratory viruses in the middle ear fluids of children with acute otitis media by multiplex reverse transcription: Polymerase chain reaction assay. Pediatr Infect Dis J2000;19:258–60.
18.
IshibashiTMonobeHNomuraYShinogamiMYanoJ. Multiplex nested reverse transcription–polymerase chain reaction for respiratory viruses in acute otitis media. Ann Otol Rhinol Laryngol2003;112:252–7.
19.
WhitleyRJHaydenFGReisingerKS. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J2001;20:127–33. [Erratum in Pediatr Infect Dis J 2001;20:421.].
20.
MarcotteHLavoieMC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev1998;62:71–109.
21.
StenforsLERaisanenS. Occurrence of middle ear pathogens in the nasopharynx of young individuals. A quantitative study in four age groups. Acta Otolaryngol (Stockh)1990;109:142–8.
22.
SinghPKTackBFMcCrayPBJr.WelshMJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol2000;279:L799–L805.
23.
SobinJEngquistSNordCE. Bacteriology of the maxillary sinus in healthy volunteers. Scand J Infect Dis1992;24:633–5.
24.
StenforsLE. Non-specific and specific immunity to bacterial invasion of the middle ear cavity. Int J Pediatr Otorhinolaryngol1999;49(suppl 1): S223–S226.
25.
HeikkinenTChonmaitreeT. Increasing importance of viruses in acute otitis media. Ann Med2000;32:157–63.
26.
PatelJFadenHSharmaSOgraPL. Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol1992;23:15–23.
27.
BakaletzLO. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol1995;3:110–4.
28.
TanoKGrahn-HakanssonEHolmSEHellstromS. Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM. Int J Pediatr Otorhinolaryngol2000;56:185–90.
29.
StenforsLERaisanenS. The membranous tonsillitis during infectious mononucleosis is nevertheless of bacterial origin. Int J Pediatr Otorhinolaryngol1993;26:149–55.
30.
BrookIDeleyvaF. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis. J Med Microbiol1996;44:131–4.
31.
LammME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol1997;51:311–40.
32.
BrandtzaegP. Immunocompetent cells of the upper airway: Functions in normal and diseased mucosa. Eur Arch Otorhinolaryngol1995;252(suppl 1): S8–S21.
33.
IvarssonMLundbergC. Phagocytosis in the nasopharyngeal secretion by cells from the adenoid. Acta Otolaryngol (Stockh)2001;121:517–22.
34.
HarbitzOJenssenAOSmidsrodO. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Eur J Respir Dis1984;65:512–20.
35.
VorlandLH. Lactoferrin: A multifunctional glycoprotein. APMIS1999;107:971–81.
36.
StenforsLERaisanenS. Immunoglobulin-coated bacteria on the tonsillar surface during infectious mononucleosis. J Laryngol Otol1996;110:339–42.
37.
FluckigerUJonesKFFischettiVA. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells. Infect Immun1998;66:974–9.
38.
Valentin-WeigandPJungnitzHZockARohdeMChhatwalGS. Characterization of group B streptococcal invasion in HEp-2 epithelial cells. FEMS Microbiol Lett1997;147:69–74.
39.
StenforsLEByeHMRaisanenSMyklebustR. Bacterial penetration into tonsillar surface epithelium during infectious mononucleosis. J Laryngol Otol2000;114:848–52.
40.
StromanDWRolandPSDoharJBurtW. Microbiology of normal external auditory canal. Laryngoscope2001;111:2054–9.
41.
SenturiaBHGessertCFCarrCDBaumannES. Studies concerned with tubotympanitis. Ann Otol Rhinol Laryngol1958;67:440–67.
42.
LiuYSLangRLimDJBirckHG. Microorganisms in chronic otitis media with effusion. Ann Otol Rhinol Laryngol Suppl1976;85(suppl 25):245–9.
43.
HealyGBTeeleDW. The microbiology of chronic middle ear effusions in children. Laryngoscope1977;87:1472–8.
44.
RidingKHBluestoneCDMichaelsRHCantekinEIDoyleWJPoziviakCS. Microbiology of recurrent and chronic otitis media with effusion. J Pediatr1978;93:739–43.
45.
BrowningGG. Pathology of inflammatory conditions of the external and middle ear. In: BoothJB, ed. Otology. Vol 3. London, England: Butterworth Heinemann, 1997.
46.
BrookIFrazierEHThompsonDH. Aerobic and anaerobic microbiology of external otitis. Clin Infect Dis1992;15:955–8.
47.
SanderR. Otitis externa: A practical guide to treatment and prevention. Am Fam Physician2001;63:927–36, 941–2.
48.
VartiainenEVartiainenJ. Effect of aerobic bacteriology on the clinical presentation and treatment results of chronic suppurative otitis media. J Laryngol Otol1996;110:315–8.
49.
SilvolaJPalvaT. Long-term results of pediatric primary one-stage cholesteatoma surgery. Int J Pediatr Otorhinolaryngol1999;48:101–7.
50.
BrumfittWPercivalAWilliamsJD. Estimation of bacteria and cells in urine. Assoc Clin Pathol1973;8:1–11.
51.
McGinleyKJLeydenJJMarplesRRKligmanAM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol1975;64:401–5.
52.
StenforsLERaisanenS. Quantitative analysis of the bacterial findings in otitis media. J Laryngol Otol1990;104:749–57.
53.
RaisanenSStenforsLE. Bacterial quantification — A necessary complement for the comprehension of middle ear inflammations. Int J Pediatr Otorhinolaryngol1992;23:117–24.
54.
GreinerODayPJBosshardPPImeriFAltweggMNadalD. Quantitative detection of Streptococcus pneumoniae in nasopharyngeal secretions by real-time PCR. J Clin Microbiol2001;39:3129–34.
55.
StenforsLERaisanenS. Quantity of aerobic bacteria in the bony portion of the external auditory canal of children. Int J Pediatr Otorhinolaryngol2002;66:167–73.
56.
CabendaSIPeerboomsPGvan AsseltGJFeenstraLvan der BaanS. Serous otitis media (SOM). A bacteriological study of the ear canal and the middle ear. Int J Pediatr Otorhinolaryngol1988;16:119–24.
57.
CostertonJWWatkinsL. Adherence of bacteria to foreign bodies: The role of the biofilm. In: RootRKTrunkeyDDSandeMA, eds. New surgical and medical approaches in infectious diseases. Vol 6. New York, NY: Churchill Livingstone, 1987:17–30.
58.
CostertonJWNickelJCLaddTI. Suitable methods for the comparative study of free-living and surface-associated bacterial populations. In: PoindexterESLedbetterER, eds. Bacteria in nature. New York, NY: Plenum Press, 1986:49.
59.
SundstromJAgrupCKronvallGWretlindB. Pseudomonas aeruginosa adherence to external auditory canal epithelium. Arch Otolaryngol Head Neck Surg1997;123:1287–92.
60.
StoneMFulghumRS. Bactericidal activity of wet cerumen. Ann Otol Rhinol Laryngol1984;93:183–6.
61.
BoeRSilvolaJYangJ. Human beta-defensin-1 mRNA is transcribed in tympanic membrane and adjacent auditory canal epithelium. Infect Immun1999;67:4843–6.
62.
JacobsMR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J2000;19(suppl): S47–S56.
63.
DaganRHobermanAJohnsonC. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J2001;20:829–37.
64.
GehannoPPanajotopoulosABarryB. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J2001;20:570–3.
65.
RodriguezWJSchwartzRH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J1999;18:942–4.
66.
HeikkinenTGhaffarFOkoroduduAOChonmaitreeT. Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics1998;102:296–9.
67.
BroidesALeibovitzEDaganR. Cytology of middle ear fluid during acute otitis media. Pediatr Infect Dis J2002;21:57–61.
68.
LeibovitzESatranRPiglanskyL. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?. Pediatr Infect Dis J2003;22:509–15.
69.
TurnerDLeibovitzEAranA. Acute otitis media in infants younger than two months of age: Microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J2002;21:669–74.
70.
LeibermanADaganRLeibovitzEYagupskyPFlissDM. The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol1999;49(suppl 1): S151–S153.
71.
LongSSHenretigFMTeterMJMcGowanKL. Nasopharyngeal flora and acute otitis media. Infect Immun1983;41:987–91.
72.
FadenHDuffyLWasielewskiRWolfJKrystofikDTungY. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis1997;175:1440–5.
73.
ZenniMKCheathamSHThompsonJM. Streptococcus pneumoniae colonization in the young child: Association with otitis media and resistance to penicillin. J Pediatr1995;127:533–7.
74.
MastroTDGhafoorANomaniNK. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet1991;337:156–9.
75.
LehmannDGrattenMMontgomeryJ. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J1997;16:297–305.
76.
Lloyd-EvansNO'DempseyTJBaldehI. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J1996;15:866–71.
77.
HodgesRGMacleodCMBernhardWG. Epidemic pneumococcal pneumonia: III. Pneumococcal carrier studies. Am J Hygiene1946;44:207–230.
78.
GrayBMConverseGMIIIDillonHCJr.. Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life. J Infect Dis1980;142:923–33.
79.
HendleyJOSandeMAStewartPMGwaltneyJMJr.. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis1975;132:55–61.
80.
MontgomeryJMLehmannDSmithT. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Rev Infect Dis1990;12(suppl 8): S1006–S1016.
81.
MastroTDNomaniNKIshaqZ. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J1993;12:824–30.
82.
FrederiksenBHenrichsenJ. Throat carriage of Streptococcus pneumoniae and Streptococcus pyogenes among infants and children in Zambia. J Trop Pediatr1988;34:114–7.
83.
AnianssonGAlmBAnderssonB. Nasopharyngeal colonization during the first year of life. J Infect Dis1992;165(suppl 1): S38–S42.
84.
DunlapMBHarveyHS. Host influence on upper respiratory flora. N Engl J Med1956;255:640–6.
85.
LodaFACollierAMGlezenWPStrangertKClydeWAJr.DennyFW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr1975;87:1087–93.
86.
DaganRMelamedRMuallemMPiglanskyLYagupskyP. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: Relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis1996;174:1352–5.
87.
FadenHWazMJBernsteinJMBrodskyLStanievichJOgraPL. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol1991;100:612–5.
88.
IngvarssonLLundgrenKUrsingJ. The bacterial flora in the nasopharynx in healthy children. Acta Otolaryngol Suppl (Stockh)1982(suppl 386):94–6.
89.
HowardAJDunkinKTMillarGW. Nasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children. Epidemiol Infect1988;100:193–203.
90.
HarabuchiYFadenHYamanakaNDuffyLWolfJKrystofikD. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J Infect Dis1994;170:862–6.
91.
FadenHStanievichJBrodskyLBernsteinJOgraPL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J1990;9:623–6.
92.
GiebinkGS. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis. Rev Infect Dis1981;3:342–53.
93.
KlugmanKPKoornhofHJKuhnleV. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child1986;140:1186–90.
94.
GeslinPBuu-HoiAFremauxAAcarJF. Antimicrobial resistance in Streptococcus pneumoniae: An epidemiological survey in France, 1970–1990. Clin Infect Dis1992;15:95–8.
95.
ArasonVAKristinssonKGSigurdssonJAStefansdottirGMolstadSGudmundssonS. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ1996;313:387–91.
96.
LeachAJShelby-JamesTMMayoM. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis1997;24:356–62.
97.
BrookIGoberAE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: Effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis1996;22:143–5.
98.
Abdel-HaqNAbuhammourWAsmarBThomasRDabbaghSGonzalezR. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatr Infect Dis J1999;18:647–9.
99.
DabernatHGeslinPMegraudF. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother1998;41:253–8.
100.
CohenRBingenEVaronE. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J1997;16:555–60.
101.
CohenRNavelMGranbergJ. One dose ceftriaxone vs ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J1999;18:403–9.
102.
DaganRLeibovitzEGreenbergDYagupskyPFlissDMLeibermanA. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J1998;17:880–5.
103.
DaganRLeibovitzEPiglanskyLYagupskyP. Effect of antibiotic treatment on pneumococcal nasopharyngeal carriage during and after acute otitis media: Comparison of three oral drugs. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, Calif: American Society for Microbiology, 1999: abstract 1028.
104.
MelanderEMolstadSPerssonKHanssonHBSoderstromMEkdahlK. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis1998;17:834–8.
105.
DaganRFraserDGivonNYagupskyP. Coverage of antibiotic-resistant Streptococcus pneumoniae causing acute otitis media by 7, 9, and 11-valent pneumococcal conjugate vaccines in southern Israel. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, Calif: American Society for Microbiology, 1999: abstract 1038.
106.
DaganRLeibovitzECheletzGLeibermanAYagupskyP. Antibiotic treatment in acute otitis media induces middle ear fluid super-infection with pre-existing nasopharyngeal antibiotic-resistant Streptococcus pneumoniae. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, Calif: American Society for Microbiology, 1999: abstract 1183.
107.
PrincipiNMarchisioPSchitoGCMannelliS. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J1999;18:517–23.
108.
GhaffarFFriedlandIRMcCrackenGHJr.. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J1999;18:638–46.
109.
HendersonFWGilliganPHWaitKGoffDA. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis1988;157:256–63.
110.
RosenCChristensenPHoveliusBPrellnerK. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres. Acta Otolaryngol (Stockh)1984;98:524–32.
111.
Givon-LaviNDaganRFraserDYagupskyPPoratN. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin Infect Dis1999;29:1274–80.
112.
YagupskyPPoratNFraserD. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis1998;177:1003–12.
113.
De LencastreHKristinssonKGBrito-AvoA. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. Microb Drug Resist1999;5:19–29.
114.
MarchisioPClautLRognoniA. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: Implications for management. Pediatr Infect Dis J2003;22:262–8.
115.
BrookIGoberAE. In vitro bacterial interference in the nasopharynx of otitis media-prone and non-otitis media-prone children. Arch Otolaryngol Head Neck Surg2000;126:1011–3.
116.
HendrixsonDRde la MorenaMLStathopoulosCSt GemeJWIII. Structural determinants of processing and secretion of the Haemophilus influenzae hap protein. Mol Microbiol1997;26:505–18.
117.
FinkDLCopeLDHansenEJGemeJWIII. The Hemophilus influenzae Hap autotransporter is a chymotrypsin clan serine protease and undergoes autoproteolysis via an intermolecular mechanism. J Biol Chem2001;276:39492–500.
118.
FinkDLSt GemeJWIII. Chromosomal expression of the Haemophilus influenzae Hap autotransporter allows fine-tuned regulation of adhesive potential via inhibition of intermolecular autoproteolysis. J Bacteriol2003;185:1608–15.
119.
HendrixsonDRSt GemeJWIII. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol Cell1998;2:841–50.
120.
FinkDLGreenBASt GemeJWIII. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect Immun2002;70:4902–7.
121.
FinkDLBuscherAZGreenBFernstenPSt GemeJWIII. The Haemophilus influenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain. Cell Microbiol2003;5:175–86.
122.
CutterDMasonKWHowellAPFinkDLGreenBASt GemeJWIII. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J Infect Dis2002;186:1115–21.
123.
KrasanGPCutterDBlockSLSt GemeJWIII. Adhesin expression in matched nasopharyngeal and middle ear isolates of nontypeable Haemophilus influenzae from children with acute otitis media. Infect Immun1999;67:449–54.
124.
DawidSGrassSSt GemeJWIII. Mapping of binding domains of nontypeable Haemophilus influenzae HMW1 and HMW2 adhesins. Infect Immun2001;69:307–14.
125.
GrassSBuscherAZSwordsWE. The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis. Mol Microbiol2003;48:737–51.
126.
DawidSBarenkampSJSt GemeJWIII. Variation in expression of the Haemophilus influenzae HMW adhesins: A prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A1999;96:1077–82.
127.
St GemeJWIIICutterD. The Haemophilus influenzae Hia adhesin is an autotransporter protein that remains uncleaved at the C terminus and fully cell associated. J Bacteriol2000;182:6005–13.
128.
LaarmannSCutterDJuehneTBarenkampSJSt GemeJW. The Haemophilus influenzae Hia autotransporter harbours two adhesive pockets that reside in the passenger domain and recognize the same host cell receptor. Mol Microbiol2002;46:731–43.
129.
HarveyHASwordsWEApicellaMA. The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic neisseria and haemophilus. J Autoimmun2001;16:257–62.
130.
SwordsWEBuscherBAVer Steeg IiK. Nontypeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol2000;37:13–27.
131.
SwordsWEKettererMRShaoJCampbellCAWeiserJNApicellaMA. Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol2001;3:525–36.
132.
SwordsWEChanceDLCohnLAShaoJApicellaMASmithAL. Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: An htrB mutation diminishes the colonization of human airway epithelial cells. Infect Immun2002;70:4661–8.
133.
GorterADOostrikJvan der LeyPHiemstraPSDankertJvan AlphenL. Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog2003;34:121–30.
134.
AhrenILJansonHForsgrenARiesbeckK. Protein D expression promotes the adherence and internalization of nontypeable Haemophilus influenzae into human monocytic cells. Microb Pathog2001;31:151–8.
135.
FanXGoldfineHLysenkoEWeiserJN. The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae. Mol Microbiol2001;41:1029–36.
136.
NovotnyLAJurcisekJAPichicheroMEBakaletzLO. Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae. Infect Immun2000;68:2119–28.
137.
HillDJTolemanMAEvansDJVillullasSVan AlphenLVirjiM. The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol Microbiol2001;39:850–62.
138.
AhrenILWilliamsDLRicePJForsgrenARiesbeckK. The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J Infect Dis2001;184:150–8.
139.
LimDJChunYMLeeHY. Cell biology of tubotympanum in relation to pathogenesis of otitis media — A review. Vaccine2000;19(suppl 1): S17–S25.
140.
MoonSKLeeHYLiJD. Activation of a Src-dependent Raf-MEK1/2-ERK signaling pathway is required for IL-1 alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells. Biochim Biophys Acta2002;1590:41–51.
141.
LysenkoESGouldJBalsRWilsonJMWeiserJN. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun2000;68:1664–71.
142.
StarnerTDSwordsWEApicellaMAMcCrayPBJr.. Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect Immun2002;70:5287–9.
143.
CraigJECliffeAGarnettKHighNJ. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol Lett2001;203:55–61.
144.
CraigJENobbsAHighNJ. The extracytoplasmic sigma factor, final sigma(E), is required for intracellular survival of nontypeable Haemophilus influenzae in J774 macrophages. Infect Immun2002;70:708–15.
TettelinHNelsonKEPaulsenIT. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science2001;293:498–506.
147.
MusserJMKaplanSL. Pneumococcal research transformed. N Engl J Med2001;345:1206–7.
148.
TongHHWeiserJNJamesMADeMariaTF. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect Immun2001;69:602–6.
149.
CundellDRWeiserJNShenJYoungATuomanenEI. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun1995;63:757–61.
150.
RosenowCRyanPWeiserJN. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol1997;25:819–29.
151.
HolmesARMcNabRMillsapKW. The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol Microbiol2001;41:1395–408.
152.
BalachandranPBrooks-WalterAVirolainen-JulkunenAHollingsheadSKBrilesDE. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun2002;70:2526–34.
153.
MageeADYotherJ. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun2001;69:3755–61.
154.
BerryAMPatonJC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun2000;68:133–40.
155.
TongHHBlueLEJamesMADeMariaTF. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun2000;68:921–4.
156.
MurdochCReadRCZhangQFinnA. Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule 1 (CD54) by human alveolar epithelial cells. J Infect Dis2002;186:1253–60.
157.
HammerschmidtSBetheGRemanePHChhatwalGS. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun1999;67:1683–7.
158.
HammerschmidtSTilligMPWolffSVaermanJPChhatwalGS. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol2000;36:726–36.
159.
OverwegKPericoneCDVerhoefGG. Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun2000;68:4604–10.
160.
SpellerbergBCundellDRSandrosJ. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol1996;19:803–13.
161.
ThroupJPKoretkeKKBryantAP. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol2000;35:566–76.
162.
LauGWHaatajaSLonettoM. A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol2001;40:555–71.
163.
WizemannTMHeinrichsJHAdamouJE. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun2001;69:1593–8.
164.
MarraAAsundiJBartilsonM. Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis. Infect Immun2002;70:1422–33.
165.
PassalacquaGCanonicaGW. Treating the allergic patient: Think globally, treat globally. Allergy2002;57:876–83.
166.
JohanssonSGHourihaneJOBousquetJ. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy2001;56:813–24. [Erratum in Allergy 2001;56:1229.].
167.
PhillipsMJKnightNJManningHAbbottALTrippWG. IgE and secretory otitis media. Lancet1974;2:1176–8.
168.
WrightEDHurstDMiottoDGiguereCHamidQ. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg2000;123:533–8.
169.
JangCHKimYH. Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy. Int J Pediatr Otorhinolaryngol2003;67:531–3.
170.
HurstDSVengeP. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy2000;55:435–41.
171.
AminKHurstDSRoomansGMVengePSeveusL. Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion. Inflamm Res1999;48:626–31.
172.
HurstDSWeekleyMRamanarayananMP. Evidence of possible localized specific immunoglobulin E production in middle ear fluid as demonstrated by ELISA testing. Otolaryngol Head Neck Surg1999;121:224–30.
173.
JangCHKimYH. Characterization of cytokines present in pediatric otitis media with effusion: Comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol2002;66:37–40.
174.
IranderKBorresMPBjorkstenB. Middle ear diseases in relation to atopy and nasal metachromatic cells in infancy. Int J Pediatr Otorhinolaryngol1993;26:1–9.
175.
AlhoOPKoivuMSorriMRantakallioP. Risk factors for recurrent acute otitis media and respiratory infection in infancy. Int J Pediatr Otorhinolaryngol1990;19:151–61.
176.
LabadieRFJewettBSHartCFPrazmaJPillsburyHCIII. Allergy increases susceptibility to otitis media with effusion in a rat model. Otolaryngol Head Neck Surg1999;121:687–92.
177.
DenburgJA. Microenvironmental influences on inflammatory cell differentiation. Allergy1995;50(suppl):25–8.
178.
TakeuchiKFujitaYTomemoriTYutaAIriyoshiNSakakuraY. Analysis of T cell receptor beta chain repertoire in middle ear effusions. Ann Otol Rhinol Laryngol1996;105:213–7.
179.
BikhaziPRyanAF. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope1995;105:629–34.
180.
HurstDSVengeP. Levels of eosinophil cationic protein and myeloperoxidase from chronic middle ear effusion in patients with allergy and/or acute infection. Otolaryngol Head Neck Surg1996;114:531–44.
181.
OhashiYNakaiYTanakaAKakinokiYWashioY. Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion. Clin Otolaryngol1998;23:231–4.
182.
TakeuchiKMaesakoKYutaASakakuraY. Interleukin-8 gene expression in middle ear effusions. Ann Otol Rhinol Laryngol1994;103:404–7.
183.
MaxwellKSFitzgeraldJEBurlesonJALeonardGCarpenterRKreutzerDL. Interleukin-8 expression in otitis media. Laryngoscope1994;104:989–95.
SkonerDPDoyleWJFiremanP. Eustachian tube obstruction (ETO) after histamine nasal provocation — A double-blind dose-response study. J Allergy Clin Immunol1987;79:27–31.
186.
DemolyPCrampetteLMondainM. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol1994;94:95–108.
187.
StenstromCIngvarssonL. General illness and need of medical care in otitis prone children. Int J Pediatr Otorhinolaryngol1994;29:23–32.
188.
NaclerioRMMeierHLKagey-SobotkaA. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis1983;128:597–602.
189.
GossetPTillie-LeblondIMalaquinFDurieuJWallaertBTonnelAB. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: Interleukin-8 is not the main chemotactic factor present in nasal lavages. Clin Exp Allergy1997;27:379–88.
190.
LampinenMRakSVengeP. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy1999;29:314–22.
191.
SehmiRCromwellOWardlawAJMoqbelRKayAB. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy1993;23:1027–36.
192.
TomonagaKKuronoYMogiG. The role of nasal allergy in otitis media with effusion. A clinical study. Acta Otolaryngol Suppl (Stockh)1988(suppl 458):41–7.
193.
JeroJVirolainenAVirtanenMEskolaJKarmaPH. Factors predicting poor outcome of acute otitis media in children. In: LimDJBluestoneCDCasselbrantMKleinJOOgraPL, eds. Proceedings of the Sixth International Symposium on Recent Advances in Otitis Media. Hamilton, Canada: BC Decker, 1996:78–80.
194.
BeckerSKochTPhilippA. Allergic origin of recurrent middle ear effusion and adenoids in young children [in German]. HNO1991;39:182–4.
195.
NsouliTMNsouliSMLindeREO'MaraFScanlonRTBellantiJA. Role of food allergy in serous otitis media. Ann Allergy1994;73:215–9.
196.
HurstDS. Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear effusions and mucosal biopsies. Laryngoscope1996;106:1128–37.
197.
HallLJLukatRM. Results of allergy treatment on the eustachian tube in chronic serous otitis media. Am J Otol1981;3:116–21.
198.
McMahanJTCalenoffECroftDJBarenholtzLWeberLD. Chronic otitis media with effusion and allergy: Modified RAST analysis of 119 cases. Otolaryngol Head Neck Surg1981;89:427–31.
199.
DraperWL. Secretory otitis media in children: A study of 540 children. Laryngoscope1967;77:636–53.
200.
FernandezAAMcGovernJP. Secretory otitis media in allergic infants and children. South Med J1965;58:581–6.
201.
HurstDS. Allergy management of refractory serous otitis media. Otolaryngol Head Neck Surg1990;102:664–9.
202.
PsifidisAHatzistilianouMSamarasKAggouridakiCDaniilidisJCatriuD. Atopy and otitis media in children. In: RubenRJKarmaPH, eds. Proceedings of the Seventh International Congress of Pediatric Otorhinolaryngology. Amsterdam, the Netherlands: Elsevier Science, 1998:205.
203.
ShubichI. Otitis media with effusion and allergy control in children: A prospective study. In: LimDJBluestoneCD, eds. Proceedings of the Sixth International Symposium on Recent Advances in Otitis Media. Hamilton, Canada: BC Decker, 1995:173–4.
204.
HurstDSAminKSeveusLVengeP. Evidence of mast cell activity in the middle ears of children with otitis media with effusion. Laryngoscope1999;109:471–7.
205.
HouYHuWGHiranoTGuXX. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model. Vaccine2002;20:2375–81.
206.
Velge-RousselFMarceloPLepageACBuzoni-GatelDBoutDT. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun2000;68:969–72.
207.
SabirovAKodamaSHiranoTSuzukiMMogiG. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect Immun2001;69:2964–71.
208.
SuenagaSKodamaSUeyamaSSuzukiMMogiG. Mucosal immunity of the middle ear: Analysis at the single cell level. Laryngoscope2001;111:290–6.
209.
KodamaSSuenagaSHiranoTSuzukiMMogiG. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect Immun2000;68:2294–300.
210.
KawauchiHYamadaTIshimitsuROgasawaraK. The immunological interaction between activated nasopharyngeal mucosal immune system and adjacent tubotympanal or tracheal mucosal linings upon antigenic exposure. In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:207.
211.
GolenbockD. Macrophage activation in the middle ear during acute otitis media: Is there a fly in there? In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:35.
212.
KawauchiHIshimitsuRMurataATakahashiA. Roles of toll-like receptors in IL-15 production by upper respiratory epithelial cells. In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:318.
213.
KawauchiHTakahashiAIshimitsuRMurataA. Antihistamine inhibits IL-8 production from upper respiratory tract epithelial cells. In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:273.
214.
KerakawauchiHKuronoYMogiG. Immune responses against Streptococcus pyogenes in human palatine tonsils. Laryngoscope1997;107:634–9.
215.
KawauchiHSanoKShibaH. T-cell mucosal immunity in the nasopharynx. In: VeldmanJEPassàliDLimDJ, eds. New frontiers in immunobiology. The Hague, the Netherlands: Kugler Publications, 2000:35–41.